Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
'No! Don't Touch Me!' German Police Release Shocking Footage From Cologne On New Year's Eve 2015
Knockout Game In St. Louis: White Man Viciously Beaten 'For No Apparent Reason'
Canadian State TV Hails 'Beige Horizon' With No White People
Assad, Putin Closer Than Ever To Retaking Aleppo; Families Returning Home For First Time In 4 Years
Afghan 'Refugee' Confesses to Rape, Murder Of 19-Year-Old German Girl
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.